There have been significant advancements in the understanding of maternal–fetal disease over the past century. This narrative review summarizes the landmark studies that have advanced the understanding of thyroid pathophysiology and thyroid disease during preconception, pregnancy, and postpartum, written to commemorate the 100th year anniversary of the founding of the American Thyroid Association.
DowlingJT, FreinkelN, IngbarSH. Thyroxine-binding by sera of pregnant women. J Clin Endocrinol Metab, 1956; 16(2):280–282; doi: 10.1210/jcem-16-2-280.
3.
RobbinsJ, NelsonJH. Thyroxine binding by serum protein in pregnancy and in the newborn. J Clin Invest, 1958; 37(2):153–159; doi:10.1172/JCI103593.
4.
EngbringNH, EngstromWW. Effects of estrogen and testosterone on circulating thyroid hormone. J Clin Endocrinol Metab, 1959; 19(7):783–796; doi: 10.1210/jcem-19-7-783.
5.
GlinoerD, de NayerP, BourdouxP, et al.Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab, 1990; 71(2):276–287; doi: 10.1210/jcem-71-2-276.
6.
HershmanJM, HigginsHP, StarnesWR. Differences between thyroid stimulator in hydatidiform mole and human chorionic thyrotropin. Metabolism, 1970; 19(10):735–744; doi: 10.1016/0026-0495(70)90071-5.
7.
YoshimuraM, HershmanJM. Thyrotropic action of human chorionic gonadotropin. Thyroid, 1995; 5(5):425; doi: 10.1089/thy.1995.5.425.
8.
BraunsteinGD, HershmanJM. Comparison of serum pituitary thyrotropin and chorionic gonadotropin concentrations throughout pregnancy. J Clin Endocrinol Metab, 1976; 42(6):1123–1126; doi: 10.1210/jcem-42-6-1123.
9.
HaradaA, HershmanJM, ReedAW, et al.Comparison of thyroid stimulators and thyroid hormone concentrations in the sera of pregnant women. J Clin Endocrinol Metab, 1979; 48(5):793–797; doi: 10.1210/jcem-48-5-793.
10.
AlexanderEK, PearceEN, BrentGA, et al.2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid, 2017; 27(3):315–389; doi: 10.1089/thy.2016.0457.
11.
RotiE, FangSL, EmersonCH, et al.Placental inner ring iodothyronine deiodination: A mechanism for decreased passage of T4 and T3 from mother to fetus. Trans Assoc Am Phys, 1981; 94:183–189.
12.
GaltonVA, MartinezE, HernandezA, et al.Pregnant rat uterus expresses high levels of the type 3 iodothyronine deiodinase. J Clin Invest, 1999; 103(7):979–987; doi: 10.1172/JCI6073.
13.
SalvatoreD, LowSC, BerryM, et al.Type 3 lodothyronine deiodinase: Cloning, in vitro expression, and functional analysis of the placental selenoenzyme. J Clin Invest, 1995; 96(5):2421–2430; doi: 10.1172/JCI118299.
14.
Aboul-KhairSA, CrooksJ, TurnbullAC, et al.The physiological changes in thyroid function during pregnancy. Clin Sci, 1964; 27:195–207.
15.
DegrootLJ. Current views on formation of thyroid hormones. N Engl J Med, 1965; 272:355–363 CONCL; doi: 10.1056/NEJM196502182720706.
16.
GlinoerD, RiahiM, GrunJP, et al.Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J Clin Endocrinol Metab, 1994; 79(1):197–204; doi: 10.1210/jcem.79.1.8027226.
17.
MandelSJ, LarsenPR, SeelyEW, et al.Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med, 1990; 323(2):91–96; doi: 10.1056/NEJM199007123230204.
18.
AlexanderEK, MarquseeE, LawrenceJ, et al.Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. New Engl J Med, 2004; 351(3):241; doi: 10.1056/NEJMoa040079.
KempWN. Iodine deficiency in relation to the stillbirth problem. Can Med Assoc J, 1939; 41(4):356–361.
21.
PharoahPO, ButtfieldIH, HetzelBS. Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet, 1971; 1(7694):308; doi: 10.1016/s0140-6736(71)91040-3.
22.
CaoXY, JiangXM, DouZH, et al.Timing of vulnerability of the brain to iodine deficiency in endemic cretinism. N Engl J Med, 1994; 331(26):1739; doi: 10.1056/NEJM199412293312603.
23.
DafnisE, SabatiniS. The effect of pregnancy on renal function: Physiology and pathophysiology. Am J Med Sci, 1992; 303(3):184; doi: 10.1097/00000441-199203000-00011.
24.
BurrowGN.The Thyroid Gland in Pregnancy. W.B. Saunders Company: Philadelphia; 1972.
25.
LeungAM, PearceEN, BravermanLE. Iodine content of prenatal multivitamins in the United States. N Engl J Med, 2009; 360(9):939; doi: 360/9/939[pii]10.1056/NEJMc0807851.
26.
LeeSY, Stagnaro-GreenA, MacKayD, et al.Iodine contents in prenatal vitamins in the United States. Thyroid, 2017; 27(8):1101–1102; doi: 10.1089/thy.2017.0097.
27.
SeniorB, ChernoffHL. Iodide goiter in the newborn. Pediatrics, 1971; 47(3):510–515.
28.
BravermanLE, IngbarSH. Changes in thyroidal function during adaptation to large doses of iodide. J Clinical Invest, 1963; 42(8):1216–1231; doi: 10.1172/jci104807.
29.
WolffJ, ChaikoffIL. Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem, 1948; 174(2):555–564.
30.
EngPH, CardonaGR, FangSL, et al.Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology, 1999; 140(8):3404; doi: 10.1210/endo.140.8.6893.
31.
TheodoropoulosT, BravermanLE, VagenakisAG. Iodide-induced hypothyroidism: A potential hazard during perinatal life. Science, 1979; 205(4405):502–503; doi: 10.1126/science.451615.
32.
StanburyJB, BrownellGL, RiggsDS, et al.The iodine-deficient human thyroid gland; A preliminary report. J Clin Endocrinol Metab, 1952; 12(2):191–207; doi: 10.1210/jcem-12-2-191.
33.
LowreyGH, AsterRH, CarrEA, et al.Early diagnostic criteria of congenital hypothyroidism: A comprehensive study of forty-nine cretins. AMA J Dis Child, 1958; 96(2):131–143; doi: 10.1001/archpedi.1958.02060060133002.
34.
ShepardTH. Onset of function in the human fetal thyroid: Biochemical and radioautographic studies from organ culture. J Clin Endocrinol Metab, 1967; 27(7):945–958; doi: 10.1210/jcem-27-7-945.
35.
BeierwaltesWH, CraneHR, WegstA, et al.Radioactive iodine concentration in the fetal human thyroid gland from fall-out. JAMA, 1960; 173:1895–1902; doi: 10.1001/jama.1960.03020350013003.
36.
GitlinD, BiasucciA. Ontogenesis of immunoreactive growth hormone, follicle-stimulating hormone, thyroid-stimulating hormine, luteinizing hormone, chorionic prolactin and chorionic gonadotropin in the human conceptus. J Clin Endocrinol Metab, 1969; 29(7):926–935; doi: 10.1210/jcem-29-7-926.
37.
GreenbergAH, CzernichowP, RebaRC, et al.Observations on the maturation of thyroid function in early fetal life. J Clin Invest, 1970; 49(10):1790–1803; doi: 10.1172/JCI106397.
38.
GrumbachMM, WernerSC. Transfer of thyroid hormone across the human placenta at term. J Clin Endocrinol Metab, 1956; 16(10):1392–1395; doi: 10.1210/jcem-16-10-1392.
39.
Morreale de EscobarG, ObregonMJ, Ruiz de OñaC, et al.Transfer of thyroxine from the mother to the rat fetus near term: Effects on brain 3,5,3'-triiodothyronine deficiency. Endocrinology, 1988; 122(4):1521–1531; doi: 10.1210/endo-122-4-1521.
40.
VulsmaT, GonsMH, de VijlderJJ. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med, 1989; 321(1):13–16; doi: 10.1056/NEJM198907063210103.
41.
FisherDA, OdellWD. Acute release of thyrotropin in the newborn. J Clin Invest, 1969; 48(9):1670–1677; doi: 10.1172/JCI106132.
42.
WalfishPG. Evaluation of three thyroid-function screening tests for detecting neonatal hypothyroidism. Lancet, 1976; 1(7971):1208–1210; doi: 10.1016/s0140-6736(76)92159-0.
43.
GlorieuxJ, DussaultJH, LetarteJ, et al.Preliminary results on the mental development of hypothyroid infants detected by the Quebec Screening Program. J Pediatr, 1983; 102(1):19–22; doi: 10.1016/s0022-3476(83)80279-0.
44.
FisherDA, DussaultJH, FoleyTPJr, et al.Screening for congenital hypothyroidism: Results of screening one million North American infants. J Pediatr, 1979; 94(5):700–705; doi: 10.1016/s0022-3476(79)80133-x.
45.
American Academy of Pediatrics, RoseSR, Section on Endocrinology and Committee on Genetics American Thyroid Association, et al. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics, 2006; 117(6):2290; doi: 117/6/2290[pii].
ThillyCH, DelangeF, LagasseR, et al.Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. J Clin Endocrinol Metab, 1978; 47(2):354–360; doi: 10.1210/jcem-47-2-354.
KesterMH, Martinez de MenaR, ObregonMJ, et al.Iodothyronine levels in the human developing brain: Major regulatory roles of iodothyronine deiodinases in different areas. J Clin Endocrinol Metab, 2004; 89(7):3117–3128; doi: 10.1210/jc.2003-031832.
51.
Thorpe-BeestonJG, NicolaidesKH, FeltonCV, et al.Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med, 1991; 324(8):532–536; doi: 10.1056/NEJM199102213240805.
52.
Morreale de EscobarG, ObregonMJ, Escobar del ReyF. Role of thyroid hormone during early brain development. Eur J Endocrinol, 2004; 151Suppl 3:U25–U37; doi: 10.1530/eje.0.151u025.
53.
FisherDA, KleinAH. Thyroid development and disorders of thyroid function in the newborn. N Engl J Med, 1981; 304(12):702–712; doi: 10.1056/NEJM198103193041205.
54.
ObregonMJ, MallolJ, PastorR, et al.L-thyroxine and 3,5,3'-triiodo-L-thyronine in rat embryos before onset of fetal thyroid function. Endocrinology, 1984; 114(1):305–307; doi: 10.1210/endo-114-1-305.
PopVJ, KuijpensJL, van BaarAL, et al.Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol, 1999; 50(2):149; doi: 10.1046/j.1365-2265.1999.00639.x.
57.
CaseyBM, DasheJS, WellsCE, et al.Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol, 2005; 105(2):239; doi: 105/2/239[pii]10.1097/01.AOG.0000152345.99421.22.
58.
HaddowJE, PalomakiGE, AllanWC, et al.Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med, 1999; 341(8):549; doi: 10.1056/NEJM199908193410801.
59.
KorevaarTI, MuetzelR, MediciM, et al.Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: A population-based prospective cohort study. Lancet Diabetes Endocrinol, 2016; 4(1):35–43; doi: 10.1016/S2213-8587(15)00327-7.
60.
BravermanLE, IngbarSH, SterlingK. Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J Clin Invest, 1970; 49(5):855–864; doi: 10.1172/JCI106304.
61.
DumitrescuAM, LiaoXH, WeissRE, et al.Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. Endocrinology, 2006; 147(9):4036–4043; doi: 10.1210/en.2006-0390.
RobertsLM, WoodfordK, ZhouM, et al.Expression of the thyroid hormone transporters monocarboxylate transporter-8 (SLC16A2) and organic ion transporter-14 (SLCO1C1) at the blood-brain barrier. Endocrinology, 2008; 149(12):6251–6261; doi: 10.1210/en.2008-0378.
64.
Morreale de EscobarG, ObregonMJ, Ruiz de OnaC, et al.Comparison of maternal to fetal transfer of 3,5,3'-triiodothyronine versus thyroxine in rats, as assessed from 3,5,3'-triiodothyronine levels in fetal tissues. Acta Endocrinol (Copenh), 1989; 120(1):20–30; doi: 10.1530/acta.0.1200020.
65.
WhiteC. A foetus with congenital hereditary Graves's disease. Proc R Soc Med, 1912; 5(Obstet Gynaecol Sect):247–252.
66.
AdamsDD, PurvesHD. Abnormal responses in the assay of thyrotropins. Proc Univ Otago Med School, 1956; 34:11–12.
DirmikisSM, MunroDS. Placental transmission of thyroid-stimulating immunoglobulins. Br Med J, 1975; 2(5972):665–666; doi: 10.1136/bmj.2.5972.665.
69.
ZakarijaM, McKenzieJM. Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab, 1983; 57(5):1036–1040; doi: 10.1210/jcem-57-5-1036.
70.
AnselmoJ, CaoD, KarrisonT, et al.Fetal loss associated with excess thyroid hormone exposure. JAMA, 2004; 292(6):691–695; doi: 10.1001/jama.292.6.691.
71.
MomotaniN, NohJ, OyanagiH, et al.Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl J Med, 1986; 315(1):24–28; doi: 10.1056/NEJM198607033150104.
72.
AndersenSL, OlsenJ, WuCS, et al.Birth defects after early pregnancy use of antithyroid drugs: A Danish nationwide study. J Clin Endocrinol Metab, 2013; 98(11):4373–4381; doi: 10.1210/jc.2013-2831.
73.
LowLC, LangJ, AlexanderWD. Excretion of carbimazole and propylthiouracil in breast milk. Lancet, 1979; 2(8150):1011; doi: 10.1016/s0140-6736(79)92575-3.
74.
DongAC, Stagnaro-GreenA. Differences in diagnostic criteria mask the true prevalence of thyroid disease in pregnancy: A systematic review and meta-analysis. Thyroid, 2019; 29(2):278–289; doi: 10.1089/thy.2018.0475.
75.
Stagnaro-GreenA, RomanSH, CobinRH, et al.Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA, 1990; 264(11):1422–1425.
76.
Consortium onT, Pregnancy-Study Group on PretermB, KorevaarTIM, et al.Association of thyroid function test abnormalities and thyroid autoimmunity with preterm birth: A systematic review and meta-analysis. JAMA, 2019; 322(7):632–641; doi: 10.1001/jama.2019.10931.
77.
DosiouC, BarnesJ, SchwartzA, et al.Cost-effectiveness of universal and risk-based screening for autoimmune thyroid disease in pregnant women. J Clin Endocrinol Metab, 2012; 97(5):1536-46; doi: 10.1210/jc.2011-2884.
78.
MarakaS, OspinaNM, O'KeeffeDT, et al.Subclinical hypothyroidism in pregnancy: A systematic review and meta-analysis. Thyroid, 2016; 26(4):580–590; doi: 10.1089/thy.2015.0418.
79.
NegroR, SchwartzA, GismondiR, et al.Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab, 2010; 95(4):1699; doi: 10.1210/jc.2009-2009.
80.
LazarusJH, BestwickJP, ChannonS, et al.Antenatal thyroid screening and childhood cognitive function. N Engl J Med, 2012; 366(6):493–501; doi: 10.1056/NEJMoa1106104.
81.
CaseyBM, ThomEA, PeacemanAM, et al.Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy. N Engl J Med, 2017; 376(9):815–825; doi: 10.1056/NEJMoa1606205.
82.
MaL, QiH, ChaiX, et al.The effects of screening and intervention of subclinical hypothyroidism on pregnancy outcomes: A prospective multicenter single-blind, randomized, controlled study of thyroid function screening test during pregnancy. J Matern Fetal Neonatal Med, 2016; 29(9):1391–1394; doi: 10.3109/14767058.2015.1049150.
83.
Dhillon-SmithRK, MiddletonLJ, SunnerKK, et al.Levothyroxine in women with thyroid peroxidase antibodies before conception. N Engl J Med, 2019; 380(14):1316–1325; doi: 10.1056/NEJMoa1812537.
84.
van DijkMM, VissenbergR, FliersE, et al.Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol, 2022; 10(5):322–329; doi: 10.1016/S2213-8587(22)00045-6.
85.
HazardJB. Thyroiditis: A review. Am J Clin Pathol, 1955; 25(3):289–298; contd; doi: 10.1093/ajcp/25.3.289.
86.
AminoN, MiyaiK, OnishiT, et al.Transient hypothyroidism after delivery in autoimmune thyroiditis. J Clin Endocrinol Metab, 1976; 42(2):296–301; doi: 10.1210/jcem-42-2-296.
87.
LazarusJH, AmmariF, OrettiR, et al.Clinical aspects of recurrent postpartum thyroiditis. Br J Gen Pract, 1997; 47(418):305–308.
88.
MessutiI, CorvisieriS, BardesonoF, et al.Impact of pregnancy on prognosis of differentiated thyroid cancer: Clinical and molecular features. Eur J Endocrinol, 2014; 170(5):659–666; doi: 10.1530/EJE-13-0903.
89.
VannucchiG, PerrinoM, RossiS, et al.Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol, 2010; 162(1):145–151; doi: 10.1530/EJE-09-0761.
90.
KungAW, ChauMT, LaoTT, et al.The effect of pregnancy on thyroid nodule formation. J Clin Endocrinol Metab, 2002; 87(3):1010–1014; doi: 10.1210/jcem.87.3.8285.
91.
PapaleontiouM, HaymartMR. Thyroid nodules and cancer during pregnancy, post-partum and preconception planning: Addressing the uncertainties and challenges. Best Pract Res Clin Endocrinol Metab, 2020; 34(4):101363; doi: 10.1016/j.beem.2019.101363.
92.
ItoY, MiyauchiA, KudoT, et al.Effects of pregnancy on papillary microcarcinomas of the thyroid re-evaluated in the entire patient series at Kuma Hospital. Thyroid, 2016; 26(1):156–160; doi: 10.1089/thy.2015.0393.
93.
ShindoH, AminoN, ItoY, et al.Papillary thyroid microcarcinoma might progress during pregnancy. Thyroid, 2014; 24(5):840–844; doi: 10.1089/thy.2013.0527.
94.
SawkaAM, ThabaneL, ParleaL, et al.Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: A systematic review and meta-analysis. Thyroid, 2009; 19(5):451–457; doi: 10.1089/thy.2008.0392.
95.
GarsiJP, SchlumbergerM, RubinoC, et al.Therapeutic administration of 131I for differentiated thyroid cancer: Radiation dose to ovaries and outcome of pregnancies. J Nucl Med, 2008; 49(5):845–852; doi: 10.2967/jnumed.107.046599.
